Source: Annual Congress 2001 - Analyses of airway secretions, biopsies and serum in airway disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Faehling, M. Bachem, D. Anders, X. Kapfer, G. Trischler, M. Hetzel (Ulm, Germany). Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases. Eur Respir J 2001; 16: Suppl. 31, 2524

Member's Comments

No comment yet.

Related content which might interest you: Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts Source: Eur Respir J 2008; 31: 21-28 Year: 2008 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 A role for vascular endothelial growth factor (VEGF) in fibrosis? Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Hepatocyte growth factor – a link between neutrophilic inflammation and BOS? Source: Eur Respir J 2006; 28: Suppl. 50, 120s Year: 2006 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Hypoxia inducible factor-1? in human emphysema lung tissue Source: Eur Respir J 2011; 37: 775-783 Year: 2011 Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis? Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity Source: Eur Respir J 2003; 21: 842-847 Year: 2003 Hepatocyte growth factor (HGF) in lung allografts Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 Fibroblast growth factor 23 and Klotho contribute to airway inflammation Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018 Year: 2018 The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005